MediciNova Extends MN-166 Patent Position in Europe
MediciNova Extends MN-166 Patent Position in Europe
Filed under: drug abuse treatment cost analysis program
"Along with our recent EPO allowance for the use of ibudilast in progressive multiple sclerosis, these drug addiction and pain patent allowances solidify our exclusivity in that region for all the core development areas of the MN-166 program," noted …
Read more on Equities.com
Carolinas HealthCare System Teams With Software Company To Encourage …
Filed under: drug abuse treatment cost analysis program
Applied Health Analytics provides companies an in-depth analysis to model projected healthcare costs and offer solutions that result in healthier, more engaged employees. … services such as health risk assessments, biometric screenings and health …
Read more on Sacramento Bee
Viewpoints: 'Bad Idea' About Repealing Medicare Cost Board; Conservatives …
Filed under: drug abuse treatment cost analysis program
It costs our nation more than $ 510 billion a year, … Unfortunately, our emergency rooms, jails, homeless shelters and prisons have become an expensive alternative to treatment for so many suffering the chronic illness of substance abuse. This is …
Read more on Kaiser Health News